Eubiotics Market by Type (Probiotics, Prebiotics, Organic Acids, Essential Oils), Livestock (Swine, Poultry, Ruminant, Aquaculture), Form (Dry and Liquid), Function (Nutrition & Gut Health, Yield, Immunity, Production) - Global Forecast to 2022

 Published On: Dec, 2016 |    No of Pages: 184 |  Published By: MarketsandMarkets | Format: PDF
Request Free Sample
Global eubiotics market projected to grow at a CAGR of 7.51%

The global eubiotics market is projected to reach a value of USD 7.47 billion by 2022, growing at a CAGR of 7.51% from 2016. The demand for eubiotics in animal feed is projected to grow during the forecast period, owing to the rapidly increasing global demand for quality animal products. The eubiotics market is influenced by the growth of the awareness among consumers with respect to preventive healthcare and nutrition. The biotechnology industry is now creating an opportunity for growth in the eubiotics sector. Factors such as low shelf life of eubiotics and high cost of eubiotics leading to the rise in cost of production are restraining the growth of the market.

Probiotics segment accounted for the largest market share in 2015 among the types of eubiotics

On the basis of type, eubiotics have been segmented into probiotics, prebiotics, organic acids, and essential oils. Among these, the probiotics segment accounted for the largest market share in 2015, followed by the organic acids and prebiotics segments, respectively. Probiotics are largely used for poultry, for healthy growth.

Poultry segment led the market with the largest share in 2015

On the basis of livestock, the eubiotics market has been segmented into swine, ruminants, poultry, aquatic animals, and others, which include horses, sheep, and birds. The market was led by poultry followed by swine. Eubiotics are mixtures of carbohydrates and proteins, which help in strengthening the immune system and also act as growth promoters. Eubiotics help in adding nutritional value to animal feed.

European region dominated the market with the largest share

Europe formed the largest market for eubiotics in 2015, whereas Asia-Pacific accounted for the second-largest market share in 2015. The application of eubiotics in animal feed is estimated to increase at a faster pace in the European and Asia-Pacific regions due to the rise in demand from consumers. The farming techniques used in the region require healthy and strong farm animals, and eubiotics helps in balancing digestive systems and enhancing immunity systems of the livestock. The changing dietary pattern has led to increased meat consumption among the people of Asia-Pacific, which has led to the industrialization of meat production in the region. The demand for healthy livestock is fueling the demand for eubiotics-based animal feed.

Breakdown of profiles of primary participants is as follows:
- By Company Type: Tier 1 – 30 %, Tier 2 – 45%, and Tier 3 – 25%
- By Designation: Directors – 22%, C level – 28%, and Manager level – 50%
- By Region: North America – 35%, Europe – 23%, Asia-Pacific – 32%, and RoW – 10%

The key players identified in the global eubiotics market include Cargill (U.S.), BASF SE (Germany), E. I. du Pont de Nemours and Company (U.S.), Koninklijke DSM N. V. (Netherlands), Chr. Hansen A/S (Denmark), Novozymes (Denmark), Calpis Co., Ltd. (Japan), Lesaffre Group (France), Kemin Industries, Inc. (U.S.), Lallemand Inc. (Canada), ADDCON (Germany), Behn Meyer (Malaysia), Novus International Inc. (U.S.), and Advanced BioNutrition Corporation (U.S.).

Research Coverage:

- This study estimates the global market of eubiotics, in terms of dollar value, till 2022, segmented on the basis of type, livestock, function, and form.
- It offers a detailed qualitative and quantitative analysis of this market with reference to the competitive landscape, and preferred development strategies such as expansions and investments and to gain a larger share in the market.
- It provides a comprehensive review of major market drivers, restraints, opportunities, challenges, winning imperatives, and key issues of the market.
- It covers various important aspects of the market. These include analysis of the value chain, Porter’s Five Forces model, competitive landscape, market dynamics, market estimates, in terms of value, and future trends in the eubiotics market.

Reasons to buy this report:

From an insight perspective, this research report has focused on various levels of analyses—industry analysis (industry trends), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the eubiotics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on eubiotics offered by the top players in the global eubiotics market

• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the eubiotics market

• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for eubiotics across various regions

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global eubiotics market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global eubiotics market
TABLE OF CONTENTS

1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 STUDY SCOPE 16
1.3.1 MARKET COVERED 16
1.3.2 PERIODIZATION CONSIDERED 16
1.4 CURRENCY CONSIDERED 17
1.5 STAKEHOLDERS 17

2 RESEARCH METHODOLOGY 18
2.1 INTRODUCTION 18
2.2 RESEARCH DATA 19
2.2.1 SECONDARY DATA 19
2.2.1.1 Key data from secondary sources 19
2.2.2 PRIMARY DATA 20
2.2.2.1 Key data from primary sources 20
2.2.2.2 Key industry insights 21
2.2.2.3 Breakdown of primary interviews 21
2.3 MARKET SIZE ESTIMATION 22
2.3.1 BOTTOM-UP APPROACH 22
2.3.2 TOP-DOWN APPROACH 23
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 24
2.5 RESEARCH ASSUMPTIONS & LIMITATIONS 25
2.5.1 ASSUMPTIONS 25
2.5.2 LIMITATIONS 25

3 EXECUTIVE SUMMARY 26

4 PREMIUM INSIGHTS 30
4.1 ATTRACTIVE OPPORTUNITIES IN THE EUBIOTICS MARKET 30
4.2 EUBIOTICS MARKETS: KEY COUNTRIES 31
4.3 LIFE CYCLE ANALYSIS: EUBIOTICS MARKET, BY REGION 31
4.4 EUBIOTICS MARKET, BY TYPE 32
4.5 DEVELOPED VS. EMERGING EUBIOTICS MARKETS, 2016 VS. 2022 32
4.6 EUBIOTICS MARKET, BY FORM & REGION, 2015 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.1.1 TYPES OF EUBIOTICS 34
5.1.1.1 Probiotics 34
5.1.1.2 Prebiotics 34
5.1.1.3 Essential oils 34
5.1.1.4 Organic acids 34
5.2 MACROINDICATORS 35
5.2.1 INTRODUCTION 35
5.2.1.1 Growing population and rising demand for diversified food 35
5.2.1.2 Increase in meat production/consumption 36
5.2.1.3 Parent Market Analysis: Animal Feed Industry 37
5.3 MARKET SEGMENTATION 38
5.3.1 BY TYPE 38
5.3.2 BY FUNCTION 38
5.3.3 BY FORM 39
5.3.4 BY LIVESTOCK 39
5.4 MARKET DYNAMICS 40
5.4.1 DRIVERS 41
5.4.1.1 Increasing awareness about feed quality and safety 41
5.4.1.2 Replacing antibiotic growth promoters (AGPs) with eubiotics 42
5.4.1.3 Rising demand for manufactured animal feed 43
5.4.1.4 Growth in demand for animal protein 43
5.4.2 RESTRAINTS 44
5.4.2.1 Trade complexities due to regulatory structure 44
5.4.2.2 Food production chain increasingly complex 45
5.4.3 OPPORTUNITIES 46
5.4.3.1 Increasing investments and opportunities in Animal Nutrition 46
5.4.3.2 Heightened consumer awareness 47
5.4.3.3 Rise in the pet industry spending 48
5.4.4 CHALLENGES 49
5.4.4.1 Rise in raw material prices 49
5.4.4.2 Increasing disease outbreaks in livestock 49
5.5 REGULATORY FRAMEWORK 49
5.5.1 ANTIBIOTICS AS FEED ADDITIVES 49
5.5.2 BAN ON ANTIBIOTICS 50
5.5.2.1 Europe 50
5.5.2.2 South Korea 51
5.5.2.3 U.S. 51

6 INDUSTRY TRENDS 53
6.1 INTRODUCTION 53
6.2 VALUE CHAIN ANALYSIS 53
6.3 SUPPLY CHAIN ANALYSIS 55
6.3.1 PROMINENT COMPANIES 55
6.3.2 SMALL & MEDIUM ENTERPRISES 55
6.3.3 END USERS 56
6.4 PORTER’S FIVE FORCES ANALYSIS 56
6.4.1 INTENSITY OF COMPETITIVE RIVALRY 57
6.4.2 BARGAINING POWER OF SUPPLIERS 57
6.4.3 BARGAINING POWER OF BUYERS 58
6.4.4 THREAT OF NEW ENTRANTS 58
6.4.5 THREAT OF SUBSTITUTES 58
6.5 PATENT ANALYSIS 59

7 EUBIOTICS MARKET, BY TYPE 64
7.1 INTRODUCTION 65
7.2 PROBIOTICS 66
7.2.1 LACTOBACILLI 67
7.2.1.1 Research on lactobacilli 67
7.2.2 BIFIDOBACTERIA 67
7.2.2.1 Research on bifidobacteria 67
7.2.3 STREPTOCOCCUS THERMOPHILUS 68
7.2.4 OTHER BACTERIA 68
7.3 PREBIOTICS 69
7.3.1 INULIN 69
7.3.2 FRUCTO-OLIGOSACCHARIDES (FOS) 69
7.3.3 GALACTO-OLIGOSACCHARIDES (GOS) 70
7.3.4 MANNAN-OLIGOSACCHARIDE (MOS) 70
7.4 ORGANIC ACIDS 71
7.4.1 FORMIC ACID 71
7.4.2 LACTIC ACID 71
7.4.3 FUMARIC ACID 71
7.4.4 PROPIONIC ACID 71
7.4.5 ACETIC ACID 72
7.5 ESSENTIAL OILS 73

8 EUBIOTICS MARKET, BY LIVESTOCK 74
8.1 INTRODUCTION 75
8.1.1 KEY FEATURES 75
8.1.1.1 Modulation of microflora 75
8.1.1.2 Stimulation of immune response 75
8.1.1.3 Metabolite excretion 75
8.2 SWINE 76
8.2.1 KEY FEATURES 76
8.2.1.1 Stimulate and Neutralize 76
8.2.1.2 Protection against infection 76
8.3 POULTRY 77
8.3.1 KEY FEATURES 77
8.3.1.1 Growth and improved feed conversion rate 77
8.4 RUMINANTS 78
8.5 AQUATIC ANIMALS 79
8.6 OTHER LIVESTOCK 80

9 EUBIOTICS MARKET, BY FORM 81
9.1 INTRODUCTION 82
9.1.1 DRY FORM 83
9.1.2 LIQUID FORM 84

10 EUBIOTICS MARKET, BY FUNCTION 85
10.1 INTRODUCTION 85
10.2 NUTRITION & GUT HEALTH 86
10.3 YIELD 87
10.4 IMMUNITY 87
10.5 PRODUCTIVITY 87

11 EUBIOTICS MARKET, BY REGION 89
11.2 INTRODUCTION 90
11.3 NORTH AMERICA 91
11.3.1 U.S. 93
11.3.2 CANADA 95
11.3.3 MEXICO 96
11.4 EUROPE 97
11.4.1 U.K. 100
11.4.2 GERMANY 102
11.4.3 FRANCE 103
11.4.4 ITALY 104
11.4.5 SPAIN 105
11.4.6 RUSSIA 106
11.4.7 SWITZERLAND 107
11.4.8 REST OF EUROPE 108
11.5 ASIA-PACIFIC 110
11.5.1 CHINA 113
11.5.2 INDIA 115
11.5.3 JAPAN 116
11.5.4 AUSTRALIA 118
11.5.5 REST OF ASIA-PACIFIC 119
11.6 REST OF THE WORLD (ROW) 120
11.6.1 BRAZIL 122
11.6.2 ARGENTINA 123
11.6.3 SOUTH AFRICA 124
11.6.4 OTHERS IN ROW 125

12 COMPETITIVE LANDSCAPE 127
12.1 OVERVIEW 127
12.2 EUBIOTICS MARKET: COMPANY RANKING 128
12.3 COMPETITIVE SITUATION & TRENDS 129
12.4 EXPANSIONS & INVESTMENTS: THE KEY STRATEGY, 2010–2016 130
12.4.1 EXPANSIONS & INVESTMENTS 131
12.4.2 MERGERS & ACQUISITIONS 132
12.4.3 NEW PRODUCT LAUNCHES 133
12.4.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES 134

13 COMPANY PROFILES 135 (Company at a Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
13.1 CARGILL 135
13.2 BASF SE 139
13.3 E.I. DUPONT DE NEMOURS AND COMPANY 142
13.4 KONINKLIJKE DSM N.V. 145
13.5 CHR. HANSEN HOLDING A/S 149
13.6 NOVOZYMES 152
13.7 CALPIS CO., LTD. 156
13.8 LESAFFRE GROUP 157
13.9 KEMIN INDUSTRIES, INC. 158
13.10 LALLEMAND, INC. 160
13.11 ADDCON 163
13.12 BEHN MEYER GROUP 164
13.13 NOVUS INTERNATIONAL, INC. 166
13.14 ADVANCED BIO NUTRITION CORP 168
13.15 BENEO GROUP 169

*Details on company at a glance, recent financials, products & services, strategies & insights, & recent developments might not be captured in case of unlisted companies.

14 APPENDIX 170
14.1 INSIGHTS OF INDUSTRY EXPERTS 170
14.2 DISCUSSION GUIDE 171
14.2.1 EXPANSIONS & INVESTMENTS 173
14.2.2 MERGERS & ACQUISITIONS 175
14.2.3 NEW PRODUCT LAUNCHES 177
14.2.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES 178
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 179
14.4 AVAILABLE CUSTOMIZATIONS 181
14.5 RELATED REPORTS 181
14.6 AUTHOR DETAILS 182

LIST OF TABLES

TABLE 1 PER CAPITA CONSUMPTION OF MEAT THROUGH 2030 37
TABLE 2 TYPICAL BROILER PERFORMANCE WITH EUBIOTIC NUTRITION IN THE NETHERLANDS, 2015 42
TABLE 3 PROTEIN SUPPLY PER CAPITA FOR KEY COUNTRIES, 2006-2009 (GRAMS/DAY) 44
TABLE 4 LIST OF MAJOR PATENTS IN PROBIOTICS IN ANIMAL FEED, 2012–2016 60
TABLE 5 LIST OF MAJOR PATENTS IN PREBIOTICS IN ANIMAL FEED, 2012–2016 62
TABLE 6 LIST OF MAJOR PATENTS IN ESSENTIAL OILS IN ANIMAL FEED, 2012-2016 63
TABLE 7 EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 66
TABLE 8 EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (KT) 66
TABLE 9 PROBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 68
TABLE 10 PREBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 70
TABLE 11 ORGANIC ACIDS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 72
TABLE 12 ESSENTIAL OILS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 73
TABLE 13 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 76
TABLE 14 SWINE: EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 77
TABLE 15 POULTRY: EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 78
TABLE 16 RUMINANTS: EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 79
TABLE 17 AQUATIC ANIMALS: EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 80
TABLE 18 OTHER LIVESTOCK: EUBIOTICS MARKET SIZE, BY REGION, 2014–2022 (USD MILLION) 80
TABLE 19 EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION) 83
TABLE 20 DRY EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 83
TABLE 21 LIQUID EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 84
TABLE 22 EUBIOTICS MARKET SIZE, BY REGION, 2014-2022 (USD MILLION) 90
TABLE 23 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION) 92
TABLE 24 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 92
TABLE 25 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 93
TABLE 26 NORTH AMERICA: EUBIOTICS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION) 93
TABLE 27 U.S.: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 94
TABLE 28 U.S.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 94
TABLE 29 CANADA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 95
TABLE 30 CANADA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 96
TABLE 31 MEXICO: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 96
TABLE 32 MEXICO: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 97
TABLE 33 EUROPE: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION) 99
TABLE 34 EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 99
TABLE 35 EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 100
TABLE 36 EUROPE: EUBIOTICS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION) 100
TABLE 37 U.K.: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 101
TABLE 38 U.K.: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 101
TABLE 39 GERMANY: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 102
TABLE 40 GERMANY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 103
TABLE 41 FRANCE: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 103
TABLE 42 FRANCE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 104
TABLE 43 ITALY: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 104
TABLE 44 ITALY: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 105
TABLE 45 SPAIN: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 105
TABLE 46 SPAIN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 106
TABLE 47 RUSSIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 106
TABLE 48 RUSSIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 107
TABLE 49 SWITZERLAND: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 107
TABLE 50 SWITZERLAND: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 108
TABLE 51 REST OF EUROPE: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 109
TABLE 52 REST OF EUROPE: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 109
TABLE 53 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014–2022 (USD MILLION) 112
TABLE 54 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 112
TABLE 55 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 113
TABLE 56 ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY FORM, 2014–2022 (USD MILLION) 113
TABLE 57 CHINA: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 114
TABLE 58 CHINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 114
TABLE 59 INDIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 115
TABLE 60 INDIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 116
TABLE 61 JAPAN: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 117
TABLE 62 JAPAN: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 117
TABLE 63 AUSTRALIA: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 118
TABLE 64 AUSTRALIA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 118
TABLE 65 REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY TYPE, 2014–2022 (USD MILLION) 119
TABLE 66 REST OF ASIA-PACIFIC: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014–2022 (USD MILLION) 119
TABLE 67 ROW: EUBIOTICS MARKET SIZE, BY COUNTRY, 2014-2022 (USD MILLION) 120
TABLE 68 ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 121
TABLE 69 ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 121
TABLE 70 ROW: EUBIOTICS MARKET SIZE, BY FORM, 2014-2022 (USD MILLION) 122
TABLE 71 BRAZIL: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 122
TABLE 72 BRAZIL: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 123
TABLE 73 ARGENTINA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 123
TABLE 74 ARGENTINA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 124
TABLE 75 SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 124
TABLE 76 SOUTH AFRICA: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 125
TABLE 77 OTHERS IN ROW: EUBIOTICS MARKET SIZE, BY TYPE, 2014-2022 (USD MILLION) 125
TABLE 78 OTHERS IN ROW: EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2014-2022 (USD MILLION) 126
TABLE 79 EXPANSIONS & INVESTMENTS, 2010–2016 131
TABLE 80 MERGERS & ACQUISITIONS, 2010–2016 132
TABLE 81 NEW PRODUCT LAUNCHES, 2010–2016 133
TABLE 82 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2010–2016 134
TABLE 83 EXPANSIONS & INVESTMENTS, 2010–2016 173
TABLE 84 MERGERS & ACQUISITIONS, 2010–2016 175
TABLE 85 NEW PRODUCT LAUNCHES, 2010–2016 177
TABLE 86 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND JOINT VENTURES, 2010–2016 178

LIST OF FIGURES

FIGURE 1 EUBIOTICS MARKET SEGMENTATION 16
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 22
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 23
FIGURE 5 DATA TRIANGULATION 24
FIGURE 6 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2016 VS. 2022 27
FIGURE 7 PROBIOTICS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUBIOTICS MARKET FROM 2016 TO 2022 27
FIGURE 8 DRY FORM PROJECTED TO DOMINATE THE EUBIOTICS MARKET, 2016–2022 28
FIGURE 9 EUROPEAN REGION ACCOUNTED FOR LARGEST MARKET SHARE FOR EUBIOTICS IN 2015 29
FIGURE 10 EUBIOTICS: AN EMERGING MARKET WITH PROMISING GROWTH POTENTIAL, 2016-2022 30
FIGURE 11 GERMANY WAS THE FASTEST-GROWING MARKET FOR EUBIOTICS, 2015 31
FIGURE 12 EUROPEAN EUBIOTICS MARKET IS EXPERIENCING HIGH GROWTH 31
FIGURE 13 PROBIOTICS EXPECTED TO DOMINATE THE MARKET THROUGHOUT THE FORECAST PERIOD 32
FIGURE 14 INDIA & BRAZIL ARE PROJECTED TO BE THE MOST ATTRACTIVE MARKETS FOR EUBIOTICS DURING THE FORECAST PERIOD 32
FIGURE 15 EUROPE ACCOUNTED FOR THE LARGEST SHARE IN THE FORM SEGMENT IN 2015 33
FIGURE 16 POPULATION GROWTH TREND, 1961-2050 36
FIGURE 17 EUBIOTICS MARKET, BY TYPE 38
FIGURE 18 EUBIOTICS MARKET, BY FUNCTION 38
FIGURE 19 EUBIOTICS MARKET, BY FORM 39
FIGURE 20 EUBIOTICS MARKET, BY LIVESTOCK 39
FIGURE 21 MARKET DYNAMICS SNAPSHOT 40
FIGURE 22 NUMBER OF GMP+ FSA CERTIFIED* COMPANIES, 2009-2015 41
FIGURE 23 FOOD CHAIN APPROACH 45
FIGURE 24 FEED ADDITIVES GROWTH OUTLOOK ESTIMATED THROUGH 2022 46
FIGURE 25 CHANGE IN CONSUMER MEAT PREFERENCES, 2009 VS. 2014 47
FIGURE 26 ANNUAL SPENDING PER PET IN THE U.S., 2011-1016 48
FIGURE 27 MANUFACTURING CONTRIBUTES MAJOR VALUE TO OVERALL PRICE OF EUBIOTICS MARKET 54
FIGURE 28 RESEARCH ORGANIZATIONS & TECHNOLOGISTS: INTEGRAL PART OF SUPPLY CHAIN OF THE EUBIOTICS MARKET 55
FIGURE 29 PORTER’S FIVE FORCES ANALYSIS: EUBIOTICS MARKET 56
FIGURE 30 NUMBER OF PATENTS APPROVED FOR PROBIOTICS & PREBIOTICS IN ANIMAL FEED, 2012–2016 59
FIGURE 31 GEOGRAPHICAL ANALYSIS: PREBIOTICS AND PROBIOTICS PATENT APPROVAL, 2012–2016 59
FIGURE 32 PREBIOTICS SEGMENT TO BE THE FASTEST-GROWING IN THE EUBIOTICS MARKET 65
FIGURE 33 EUBIOTICS MARKET SIZE, BY LIVESTOCK, 2016-2022 75
FIGURE 34 DRY SEGMENT TO DOMINATE THE EUBIOTICS MARKET FROM 2016 TO 2022 82
FIGURE 35 CLASSIFICATION OF ANIMAL FEED ADDITIVES 85
FIGURE 36 EFFECT OF PROBIOTICS ON ANIMAL HEALTH 86
FIGURE 37 EUROPE: EUBIOTICS MARKET SNAPSHOT 98
FIGURE 38 CHINA WAS THE MARKET LEADER IN THE ASIA-PACIFIC REGION IN 2015 111
FIGURE 39 EXPANSIONS & INVESTMENTS: LEADING APPROACH OF KEY PLAYERS (2010–2016) 127
FIGURE 40 GLOBAL EUBIOTICS COMPANY RANKINGS (2015) 128
FIGURE 41 BATTLE FOR MARKET SHARE: EXPANSIONS AND INVESTMENTS WAS THE MOST POPULAR GROWTH STRATEGY 129
FIGURE 42 EXPANSIONS & INVESTMENTS FUELED GROWTH AND INNOVATION (2014–2016) 130
FIGURE 43 CARGILL: COMPANY SNAPSHOT 135
FIGURE 44 CARGILL: SWOT ANALYSIS 138
FIGURE 45 BASF SE: COMPANY SNAPSHOT 139
FIGURE 46 BASF SE: SWOT ANALYSIS 141
FIGURE 47 E.I. DUPONT DE NEMOURS AND COMPANY: COMPANY SNAPSHOT 142
FIGURE 48 E. I. DU PONT DE NEMOURS AND COMPANY: SWOT ANALYSIS 144
FIGURE 49 KONINKLIJKE DSM N.V. : COMPANY SNAPSHOT 145
FIGURE 50 KONINKLIJKE DSM N. V.: SWOT ANALYSIS 147
FIGURE 51 CHR. HANSEN A/S: COMPANY SNAPSHOT 149
FIGURE 52 CHR. HANSEN A/S: SWOT ANALYSIS 151
FIGURE 53 NOVOZYMES: COMPANY SNAPSHOT 152

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.